(Q33600121)

28 July 2017

1 reference

title

Mechanism of erythropoietin-induced hypertension (English)

1 reference

28 July 2017

main subject

arterial hypertension

0 references

1 reference

Vaziri ND

1

1 reference

28 July 2017

publication date

1 May 1999

1 reference

American Journal of Kidney Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

33

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

821-828

1 reference

Erythropoietin: physiologic and pharmacologic aspects

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Hypertension following erythropoietin therapy in anemic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Hemodynamics of uremic anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Blood pressure, erythropoietin, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Blood pressure changes during treatment with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Effects of Hematocrit Variations on Cerebral Blood Flow and Oxygen Transport in Ischemic Cerebrovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Erythropoietin for end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Endothelin Release and Shift in Prostaglandin Balance Are Involved in the Modulation of Vascular Tone by Recombinant Erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Lack of a fast-acting effect of erythropoietin on arterial blood pressure and endothelin level

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Fura-2 used as a probe to show elevated intracellular free calcium in platelets of Dahl-sensitive rats fed a high salt diet.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Plasma Na-K ATPase inhibitor activity and intracellular ions during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Decreased intracellular free magnesium in erythrocytes of spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Ca2+ localization and sensitivity in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Erythropoietin receptor-operated Ca2+ channels: activation by phospholipase C-gamma 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Mechanisms of erythropoietin signal transduction: involvement of calcium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Recombinant human erythropoietin stimulates angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Effect of erythropoietin on DNA synthesis, proto-oncogene expression and phospholipase C activity in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970413-0

7 January 2021

10.1016/S0272-6386(99)70413-0

Identifiers

DOI

1 reference

28 July 2017

1 reference